Steven Lichtman
Stock Analyst at William Blair
(4.78)
# 581
Out of 4,690 analysts
1006
Total ratings
53.8%
Success rate
15.1%
Average return
Main Sectors:
Stocks Rated by Steven Lichtman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MMED MiniMed Group | Maintained: Buy | n/a | $20.10 | - | 3 | Aug 25, 2026 | |
| TNDM Tandem Diabetes Care | Initiated Coverage: Buy | n/a | $21.43 | - | 44 | Aug 21, 2026 | |
| BBNX Beta Bionics | Initiated Coverage: Hold | n/a | $19.72 | - | 1 | Aug 21, 2026 | |
| COO The Cooper Companies | Maintained: Buy | n/a | $71.17 | - | 31 | Aug 18, 2026 | |
| ENOV Enovis | Maintained: Buy | n/a | $24.90 | - | 3 | Aug 14, 2026 | |
| SWX: ALC Alcon Inc. | Rated: Hold | n/a | $57.90 | - | 8 | Aug 12, 2026 | |
| OWLT Owlet | Maintained: Buy | n/a | $4.99 | - | 1 | Aug 12, 2026 | |
| RXST RxSight | Maintained: Hold | n/a | $7.05 | - | 16 | Aug 7, 2026 | |
| ZBH Zimmer Biomet Holdings | Maintained: Hold | n/a | $100.91 | - | 73 | Aug 6, 2026 | |
| SGHT Sight Sciences | Maintained: Buy | n/a | $8.55 | - | 4 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $145.13 | - | 65 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $90.82 | - | 90 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $330.69 | - | 53 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $8.43 | - | 1 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $179.87 | - | 16 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 → $15 | $3.95 | +279.75% | 22 | Sep 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $118 | $46.84 | n/a | 81 | Aug 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 → $7.5 | $14.30 | n/a | 22 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $73 → $78 | $82.97 | n/a | 69 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $87 → $116 | $90.49 | n/a | 14 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $16 | $15.85 | n/a | 6 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $275 | $321.68 | n/a | 1 | Dec 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $22.11 | n/a | 5 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $92 → $94 | $91.23 | n/a | 146 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $16.89 | n/a | 123 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.5 | $3.46 | n/a | 3 | Sep 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 17 | Feb 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.74 | n/a | 15 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.34 | n/a | 8 | Dec 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $7.46 | n/a | 13 | Dec 18, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $237 | $278.88 | n/a | 1 | Feb 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.71 | n/a | 11 | May 27, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.8889 | n/a | 26 | Mar 4, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.85 | n/a | 13 | Mar 13, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.45 | n/a | 1 | Oct 7, 2011 |
MiniMed Group
Aug 25, 2026
Maintained: Buy
Price Target: n/a
Current: $20.10
Upside: -
Tandem Diabetes Care
Aug 21, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $21.43
Upside: -
Beta Bionics
Aug 21, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $19.72
Upside: -
The Cooper Companies
Aug 18, 2026
Maintained: Buy
Price Target: n/a
Current: $71.17
Upside: -
Enovis
Aug 14, 2026
Maintained: Buy
Price Target: n/a
Current: $24.90
Upside: -
Alcon Inc.
Aug 12, 2026
Rated: Hold
Price Target: n/a
Current: $57.90
Upside: -
Owlet
Aug 12, 2026
Maintained: Buy
Price Target: n/a
Current: $4.99
Upside: -
RxSight
Aug 7, 2026
Maintained: Hold
Price Target: n/a
Current: $7.05
Upside: -
Zimmer Biomet Holdings
Aug 6, 2026
Maintained: Hold
Price Target: n/a
Current: $100.91
Upside: -
Sight Sciences
Aug 6, 2026
Maintained: Buy
Price Target: n/a
Current: $8.55
Upside: -
Aug 5, 2026
Maintained: Buy
Price Target: n/a
Current: $145.13
Upside: -
Jul 31, 2026
Maintained: Buy
Price Target: n/a
Current: $90.82
Upside: -
Jul 31, 2026
Maintained: Buy
Price Target: n/a
Current: $330.69
Upside: -
Jul 31, 2026
Maintained: Buy
Price Target: n/a
Current: $8.43
Upside: -
Jul 30, 2026
Maintained: Buy
Price Target: n/a
Current: $179.87
Upside: -
Sep 5, 2025
Maintained: Buy
Price Target: $12 → $15
Current: $3.95
Upside: +279.75%
Aug 3, 2025
Maintained: Hold
Price Target: $118
Current: $46.84
Upside: n/a
May 14, 2025
Maintained: Buy
Price Target: $11 → $7.5
Current: $14.30
Upside: n/a
May 9, 2025
Maintained: Hold
Price Target: $73 → $78
Current: $82.97
Upside: n/a
Feb 26, 2025
Maintained: Buy
Price Target: $87 → $116
Current: $90.49
Upside: n/a
Jan 10, 2025
Maintained: Buy
Price Target: $13 → $16
Current: $15.85
Upside: n/a
Dec 16, 2024
Initiated Coverage: Buy
Price Target: $275
Current: $321.68
Upside: n/a
Nov 1, 2024
Maintained: Hold
Price Target: n/a
Current: $22.11
Upside: n/a
Aug 21, 2024
Maintained: Hold
Price Target: $92 → $94
Current: $91.23
Upside: n/a
May 7, 2024
Downgraded: Hold
Price Target: n/a
Current: $16.89
Upside: n/a
Sep 19, 2023
Maintained: Buy
Price Target: $3.5
Current: $3.46
Upside: n/a
Feb 6, 2023
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Aug 10, 2022
Downgraded: Hold
Price Target: n/a
Current: $1.74
Upside: n/a
Dec 31, 2020
Rated: Hold
Price Target: n/a
Current: $2.34
Upside: n/a
Dec 18, 2018
Rated: Hold
Price Target: n/a
Current: $7.46
Upside: n/a
Feb 8, 2018
Reiterated: Buy
Price Target: $237
Current: $278.88
Upside: n/a
May 27, 2016
Reiterated: Hold
Price Target: n/a
Current: $1.71
Upside: n/a
Mar 4, 2016
Downgraded: Hold
Price Target: n/a
Current: $0.8889
Upside: n/a
Mar 13, 2015
Downgraded: Hold
Price Target: n/a
Current: $0.85
Upside: n/a
Oct 7, 2011
Downgraded: Hold
Price Target: n/a
Current: $1.45
Upside: n/a